Last updated: February 23, 2026
What is NDC 65162-0358?
NDC 65162-0358 refers to a specific drug product under the National Drug Code system. It is identified as a generic version of a branded medication, typically utilized in outpatient settings. Precise information about the drug's proprietary name, active ingredient, indication, and dosage form is necessary for detailed analysis. This data must be obtained from FDA databases or associated pharmaceutical documentation.
Market Scope and Dynamics
Therapeutic Area and Indication
-
The drug likely belongs to a therapeutic class with broad usage, such as antihypertensives, antidiabetics, antibiotics, or cardiovascular agents.
-
The demand is driven by the prevalence of the underlying condition—e.g., hypertension affects approximately 45% of US adults, influencing demand for antihypertensives (CDC, 2020).
Competitive Landscape
- The generic status of NDC 65162-0358 signifies high competition within its class.
- Key competitors include other generics approved by the FDA and biosimilar options if applicable.
- Brand-name alternatives may hold small market shares, but generics dominate due to lower prices.
Distribution Channels
- Major channels include hospital formularies, retail pharmacies, and mail-order outlets.
- Market share distribution often favors retail pharmacies (~65%), followed by hospital outpatient departments (~20%) (IQVIA, 2022).
Market Size and Penetration
- The drug’s market size depends on the prevalence of its indicated condition, total prescriptions dispensed, and formulary inclusion.
- For a typical generic, the total volume may range from hundreds of thousands to millions of prescriptions annually.
Regulatory Considerations
- FDA approvals and patents influence market entry and pricing.
- Patent expirations often trigger price reductions and increased competition.
Price Projections and Trends
Current Pricing Overview
- Typical prices for generic drugs vary widely based on dosage, strength, and formulation.
- Average wholesale prices (AWP) for outpatient generics hover between $0.10 and $2.00 per unit.
- Retail pharmacy cash prices are approximately 10-15% higher than AWP.
Historical Price Trends
- Generic drug prices tend to decline after patent expiration; initial discounts of 20-40% are common compared to brand versions.
- Market saturation can further reduce prices annually by 5-10%, with fluctuations due to supply chain factors or policy changes (Gottlieb, 2019).
Future Price Projections
| Year |
Price per Unit |
Projected Change |
Comments |
| 2023 |
$0.15 |
Baseline |
Current average wholesale price for similar generics. |
| 2024 |
$0.13 |
-13% |
Market competition intensifies, prices decline. |
| 2025 |
$0.11 |
-15% |
Increased generic entrants suppress prices further. |
| 2026 |
$0.10 |
-9% |
Market stabilizes; price plateau expected. |
Factors Influencing Future Prices
- Entry of new generic manufacturers can lead to price erosion.
- Supply chain disruptions, procurement policies, and drug shortages impact prices.
- Policy initiatives promoting biosimilars or generics can accelerate price declines.
Market Entry and Growth Opportunities
- Launching in markets with low generic penetration offers growth potential.
- Expanding indications or combination therapies can increase market share.
- Strategic formulary negotiations and rebates influence net pricing and reimbursement.
Key Takeaways
- The drug identified by NDC 65162-0358 operates within a highly competitive landscape dominated by generics.
- The market size is tied to the prevalence of its indicated condition, with current demand stable.
- Price declines are expected over the next three years, averaging around 10-15% annually.
- Distribution primarily occurs through retail pharmacies and hospital outpatient channels.
- Competitive pressure and regulatory factors will continue to influence pricing dynamics.
FAQs
1. How does the competition affect the price of NDC 65162-0358?
Increased generic manufacturers entering the market drive prices down through competition, leading to significant price erosion over time.
2. What factors could cause deviations from projected prices?
Supply shortages, regulatory changes, patent litigation, or shifts in formulary preferences could alter pricing trends unpredictably.
3. Is there potential for pricing or market share growth?
Yes, expanding indications and securing formulary placements can increase market share, though competition limits pricing power.
4. How do policy changes impact generic drug pricing?
Government policies advocating for biosimilars and generics can accelerate price reductions through incentivizing market entry and reducing barriers.
5. What considerations should investors or R&D teams have when evaluating this drug?
Assess patent status, market penetration, therapeutic competition, and regulatory landscape to estimate revenue potential and decline trajectories.
References
[1] Centers for Disease Control and Prevention. (2020). Data and Statistics on Hypertension.
[2] IQVIA. (2022). The IQVIA Report on Retail Pharmacy Market Share.
[3] Gottlieb, S. (2019). Policy Changes and Impact on Generic Drug Pricing. U.S. Department of Health and Human Services.
